MMWR Morb Mortal Wkly Rep. 2013 Dec 6;62(48):973-8.
Asthma was the most common underlying condition among persons hospitalized with pandemic influenza A (H1N1) virus infection in 2009. Although persons with asthma are not more likely than others to get influenza, influenza can make asthma symptoms worse, trigger asthma attacks, and lead to pneumonia or other complications that result in hospitalization and even death. During 1964-2010, the Advisory Committee on Immunization Practices (ACIP) recommended that all adults and children aged ≥6 months with asthma receive an influenza vaccination annually. Beginning with the 2010-11 influenza season, ACIP expanded its annual vaccination recommendation to include all persons aged ≥6 months, while emphasizing that protection of persons at higher risk for influenza-related complications continue as a focus of vaccination efforts. To provide the first update of national vaccination coverage among persons aged ≥2 years with asthma since the new ACIP recommendation, CDC analyzed data from the 2010 and 2011 National Health Interview Survey (NHIS). This report describes the results of that analysis, which indicated that influenza vaccination during the 2010-11 season among persons with asthma was 50%, up from 36% 5 years earlier. However, vaccination coverage across all age groups, including among those with health insurance, a usual place for health care, and one or more health-care visits in the past 12 months, remained well below Healthy People 2020 targets of 80% for children aged 6 months-17 years and 90% for adults aged ≥18 years who are at high risk. These findings highlight the need to educate health-care providers and persons with asthma about the importance of annual influenza vaccination.
在 2009 年因感染大流行性流感 A(H1N1)病毒而住院的患者中,哮喘是最常见的基础疾病。尽管哮喘患者感染流感的可能性并不比其他人高,但流感会使哮喘症状恶化,引发哮喘发作,并导致肺炎或其他并发症,从而需要住院治疗,甚至导致死亡。在 1964 年至 2010 年期间,免疫实践咨询委员会(ACIP)建议所有患有哮喘的成年人和 6 个月以上的儿童每年接种流感疫苗。从 2010-2011 年流感季节开始,ACIP 将其年度接种建议扩大到包括所有 6 个月以上的人群,同时强调保护那些有更高流感相关并发症风险的人群仍然是接种工作的重点。为了提供自新的 ACIP 建议以来,首次更新患有哮喘的 2 岁以上人群的全国疫苗接种覆盖率,CDC 分析了 2010 年和 2011 年全国健康访谈调查(NHIS)的数据。本报告描述了该分析的结果,表明在 2010-2011 年流感季节,哮喘患者的流感疫苗接种率为 50%,高于 5 年前的 36%。然而,包括有医疗保险、常规医疗保健场所和过去 12 个月内有一次或多次医疗保健就诊的所有年龄段的疫苗接种率,仍远低于“2020 年健康人”目标,即 6 个月至 17 岁儿童的接种率为 80%,18 岁及以上高危成年人的接种率为 90%。这些发现强调了需要教育医疗保健提供者和哮喘患者年度流感疫苗接种的重要性。